BCEC Quarterly Economic Commentary – March 2019
MetadataShow full item record
This Western Australia Quarterly Economic Commentary analyses the most recent data on economic and social indicators for WA, as at Q1 2019.
This quarter we see that falling private sector investment is dragging the WA economy into negative growth territory. The decline in SFD (trend) in the quarter to December 2018 of 0.1% would be worse if not for the protection currently provided by growth in public consumption expenditure and public investment.
Showing items related by title, author, creator and subject.
Efficacy and Safety of Quarter-Dose Blood Pressure-Lowering Agents: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsBennett, A.; Chow, C.; Chou, M.; Dehbi, H.; Webster, R.; Salam, A.; Patel, A.; Neal, B.; Peiris, D.; Thakkar, J.; Chalmers, J.; Nelson, M.; Reid, Christopher; Hillis, G.; Woodward, M.; Hilmer, S.; Usherwood, T.; Thom, S.; Rodgers, A. (2017)There is a critical need for blood pressure-lowering strategies that have greater efficacy and minimal side effects. Low-dose combinations hold promise in this regard, but there are few data on very-low-dose therapy. We, ...
Effect of pre-cooling on repeat-sprint performance in seasonally acclimatised males during an outdoor simulated team-sport protocol in warm conditionsBrade, Carly; Dawson, B.; Wallman, K. (2013)Whether precooling is beneficial for exercise performance in warm climates when heat acclimatised is unclear. The purpose of this study was to determine the effect of precooling on repeatsprint performance during a simulated ...
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic reviewChow, C.; Thakkar, J.; Bennett, A.; Hillis, G.; Burke, M.; Usherwood, T.; Vo, K.; Rogers, K.; Atkins, E.; Webster, R.; Chou, M.; Dehbi, H.; Salam, A.; Patel, A.; Neal, B.; Peiris, D.; Krum, H.; Chalmers, J.; Nelson, M.; Reid, Christopher; Woodward, M.; Hilmer, S.; Thom, S.; Rodgers, A. (2017)Â© 2017 Elsevier Ltd Background Globally, most patients with hypertension are treated with monotherapy, and control rates are poor because monotherapy only reduces blood pressure by around 9/5 mm Hg on average. There is ...